Drawing for UNITHER

USPTO serial 77347088

UNITHER

Reviewed by CopyMark Law Group

Reg. 3629454Status 800Registered
Filing date
Status date
Registration date
Jun 2, 2009
Examiner
FRAZIER, TAMARA G
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with UNITHER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebeccah Gan

Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.4000 Legato Road, Suite 310Fairfax, VA 22033UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical antitussive-cold preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical sedative preparations; Pharmaceutical preparations for use in urology; Yeast or yeast extracts for medical or pharmaceutical purposes; Pharmaceutical products for ophthalmologic use; Pharmaceutical preparations for wounds; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for human skincare; Anti-diabetic pharmaceuticals; Pharmaceutical antiseptic preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a drug delivery system comprising oral alcoholic liquid for per lingual release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Unit dose capsules sold empty for pharmaceutical use ]SECTION 7(e) - CANCELLED—
010Aerosol dispensers for medical use; Dropper bottles for administering medication, sold empty; Droppers for administering medication, sold empty; Drug delivery systems; Use dose bottles and capsules for per lingual delivering medicationACTIVE—
042[ Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Research and development of pharmaceutical capsules for pharmaceutical use ] * Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Research and development of pharmaceutical capsules for pharmaceutical use; all of the foregoing for use in connection with custom manufacturing of pharmaceuticals or packaging for third parties *ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 27, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 27, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 27, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 27, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 27, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 16, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 16, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 16, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 16, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 5, 2019NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED—
Jul 5, 2019RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jul 5, 201989AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jul 5, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 28, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 28, 2019E89RTEAS SECTION 8 & 9 RECEIVED—
Jun 2, 2018REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 22, 2015TMBNTTAB RELEASE CASE TO TRADEMARKS—
Dec 22, 2015CANTCANCELLATION TERMINATED NO. 999999—
Nov 20, 2015A7OKAMENDMENT UNDER SECTION 7 - PROCESSED—
Nov 20, 2015PLGLASSIGNED TO PARALEGAL—
Nov 20, 2015CANDCANCELLATION DENIED NO. 999999—
Oct 16, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 3, 2015CORVREVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD—
Jul 30, 2015EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 28, 2015NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
May 28, 20158.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
May 20, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 18, 2015ES8RTEAS SECTION 8 RECEIVED—
Nov 19, 2014ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 2, 2014PETCCANCELLATION INSTITUTED NO. 999999—
Jan 4, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 2, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 17, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 25, 2009NPUBNOTICE OF PUBLICATION—
Feb 10, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 6, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 3, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 2, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 2, 2009ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 27, 2009RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 22, 2009RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 22, 2008CNSLLETTER OF SUSPENSION MAILED—
Jul 21, 2008CNSLSUSPENSION LETTER WRITTEN—
Jul 3, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 3, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 3, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 19, 2008CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2008DOCKASSIGNED TO EXAMINER—
Mar 16, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 6, 2008AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 6, 2008ALIEASSIGNED TO LIE—
Feb 7, 2008PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 12, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance